UK biotech firm skyrockets 552% after drug lowers odds of serious COVID-19 symptoms

· *UK biotech firm Synairgen surged as much as 552% on Monday after the company announced its experimental coronavirus drug helped curb the contraction of serious COVID-19 symptoms.*
· *The SNG001 drug cut the odds of a patient requiring ventilation or dying by 79% compared to those receiving a placebo, the company said.*
·...